Flora Growth Corp

Flora Growth Corp. engages in the production of organic cannabis and pharmaceutical-grade medical products. It operates through the following segments: Cultivation, Processing, and Supplying of Natural, Medicinal-Grade Cannabis Oil and High Quality Cannabis; Over-the-Counter Medical Products and Medical Cannabis Products; Wellbeing Products; and Food and Beverage Products. The company was founded on March 13, 2019 and is headquartered in Toronto, Canada.

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Flora Growth Corp. engages in the production of organic cannabis and pharmaceutical-grade medical products. It operates through the following segments: Cultivation, Processing, and Supplying of Natural, Medicinal-Grade Cannabis Oil and High Quality Cannabis, Over-the-Counter Medical Products and Medical Cannabis Products, Wellbeing Products, and Food and Beverage Products. The company was founded on March 13, 2019 and is headquartered in Fort Lauderdale, FL.

Colombia-based cannabis cultivator and producer Flora Growth Corp. (NASDAQ:FLGC) has expanded into the United Kingdom and Costa Rica. The move comes on the heels of its initial public offering pricing announcement of 3,333,333 common stock shares that will net the company $16,666,665 in financing.

Flora Growth Expands In UK And Costa Rica, Fulfills Orders Of Mambe, Almost Virgin And Mind Naturals Products

Aurora Cannabis

Applied DNA Sciences

Arena Pharmaceuticals

Cara Therapeutics

Canopy Growth

Corbus Pharmaceuticals Holdings

GrowGeneration Corp

HEXO Corp

Akerna Corp

OrganiGram Holdings Inc.

SNDL Inc.

Village Farms International

cbdMD Inc

Zynerba Pharmaceuticals

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and look ahead to how the cannabis industry continues to take shape in 2021.

Here Are the Cannabis Stocks That Caught Fire This Week

Flora Growth's Mambe, Mind Naturals, and Almost Virgin Brands Fulfill Initial Orders in New Markets; Company Reaches Significant Milestones as It Continues to Execute On Its International Growth Strategy Flora Growth's Mambe, Mind Naturals, and Almost Virgin Brands Fulfill Initial Orders in New Markets; Company Reaches Significant Milestones as It Continues to Execute On Its International Growth Strategy

Flora Growth Expands into U.K. and Central American Markets with Sales to New International Distribution Partners

TORONTO, May 13, 2021 (GLOBE NEWSWIRE) -- Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), an all-outdoor cultivator and manufacturer of cannabis-derived products and brands, today announced the closing of its initial public offering of 3,333,333 of its common shares.

Flora Growth Corp. Announces Closing of Initial Public Offering

News for Flora Growth Corp Stock (FLGC)